Weiping Zou, M.D., Ph.D.

Dr. Zou is the Charles B. de Nancrede Professor; Professor of Pathology, Immunology, Biology and Surgery; Director of the Center of Excellence for Cancer Immunology and Immunotherapy; and Co-Director of the Cancer Hematopoiesis and Immunology Program at the University of Michigan School of Medicine and Rogel Cancer Center. Dr. Zou leads a multidisciplinary laboratory that investigates the human cancer microenvironment with the goal of understanding the nature of human tumor immune responses and developing mechanism-informed combination therapies for cancer. His laboratory has demonstrated that the interaction between tumor cells and the host immune system fosters tumor immunosuppressive networks and results in cancer progression and therapeutic resistance. Dr. Zou earned his M.D. from the Tongji Medical College in China and Ph.D. from the University of Paris in France. • Lieping Chen, M.D., Ph.D.
• Mario Sznol, M.D.

• Stephen Miller, Ph.D.

• Ursula Matulonis, M.D.

• Weiping Zou, M.D, Ph.D.

• Brahm Segal, M.D.

• Lisa M. Coussens, Ph.D.